Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
VOICEplug AI and OpenTable Announce Global Integration to Automate Table Reservations
-
Top 10 Budget-Friendly ASIC Miners for New Bitcoin Miners
-
Abyrx and Kairuku Launch MedEdge Holdings with $450 Million Transaction
-
TNL Mediagene Announces GIZMART's Debut Project Keychron Nape Pro Hits ¥100 million in GMV in 12 Hours, Validating New Digital Media-Commerce Strategy
-
Cannara Biotech Delivers Record Fiscal 2025 Revenue and Profitability, Achieves First Year of Positive Retained Earnings
-
Proconex Launches Linque, a New Industrial Intelligence Company Connecting Organizations to the Future of Industry
-
bidadoo Achieves Record Q3, Strengthening Position as Leading Online Auction Platform
-
Clear Channel Outdoor Holdings, Inc. to Participate in the Bank of America 2025 Leveraged Finance Conference
-
ezAccounting Highlights 2025 W2 Form Now Available for Tax Professionals
-
BioLineRx Reports Third Quarter 2025 Financial Results and Provides Corporate Update
-
Tonix Pharmaceuticals Announces FDA IND Clearance for Phase 2 Study of TNX-102 SL for the Treatment of Major Depressive Disorder
-
Click-to-Ship: Jambojet Joins Freightos by WebCargo, Expanding Digital Cargo Connectivity Across East Africa
-
QuidelOrtho To Participate In Upcoming Investor Conferences
-
Capital Square LLC Offering to Fund Second Development of Single-Family Build-For-Rent (BFR) Community Near Phoenix with Sunstone Two Tree
-
Ituran Signs New OEM Agreement with Renault in Latin America
-
Dianthus Therapeutics To Participate in the 8th Annual Evercore Healthcare Conference
-
WESTERN MIDSTREAM ANNOUNCES THIRD-QUARTER POST-EARNINGS INTERVIEW WITH CFO, KRISTEN SHULTS AND PARTICIPATION IN UPCOMING INVESTOR CONFERENCES
-
Eiger Express Pipeline Capacity Expansion
-
CervoMed to Share New Data on Neflamapimod as a Treatment for Dementia with Lewy Bodies at the 18th Clinical Trials on Alzheimer's Disease (CTAD) Conference
-
Data from Genprex's Acclaim-1 Phase 1 Gene Therapy Clinical Trial Published in Clinical Lung Cancer
-
Definity Joins Vercel's Exclusive Partner Program to Accelerate Enterprise AI & Digital Experience Deployment
-
Pando Named a Fastest-Growing Company in North America on the 2025 Deloitte Technology Fast 500™
-
SuperX Appoints Former Intel GM Ken Lau as Chief Strategy Officer and Executive Director to Strengthen Global Supply Chain
-
Hollywood Racks Announces Two New Accessories for its CrossTrack Series
-
Kymera Therapeutics to Participate in Upcoming December Investor Conferences
-
Kelun-Biotech Announces Phase III Trial of Sac-TMT in Combination with KEYTRUDA® (pembrolizumab) as First-Line Treatment for PD-L1-Positive NSCLC Met Primary Endpoint
-
Vehicle Management Solutions Expands Safety Service Patrol Capabilities with the Acquisition of AutoBase
-
Aldebaran Files PEA on Sedar+ and Announces Termination of the Option Agreement with Nuton Holdings Ltd.
-
Dowling Catholic High School Improves Campus Safety and Communication with Sangoma and Quicklert
-
Black Friday Must-Have: YESOUL G1 M PLUS Indoor Bike for Efficient Winter Home Workouts
-
Gaming and Leisure Properties, Inc. Declares Fourth Quarter 2025 Cash Dividend of $0.78 Per Share
-
X-energy Closes Oversubscribed $700 Million Series D Financing Round to Continue Expansion to Meet Global Energy Demand
-
AlphaTON Capital Submits Strategic Offer to Acquire Majority Stake in Forbes Media Holdings
-
Edify Engine Unveils Agency & Studio Solutions, Delivering Scalable 3D World Production for Professional Creative Teams
-
RAMPSociety™ Welcomes JDL Access as New Corporate Member
-
Edify Engine Unveils Agency & Studio Solutions, Delivering Scalable 3D World Production for Professional Creative Teams
-
Can-Fite to Advance New Veterinary Partnership Opportunities for Namodenoson at the BioFIT 2025 Conference
-
Pasithea Therapeutics Announces Completion of Cohort 7 in Ongoing Phase 1 Trial of PAS-004 in Advanced Cancer Patients, with Positive Safety, Pharmacokinetic (PK), and Pharmacodynamic (PD) Data
-
DraftKings Set to Launch Mobile Sports Wagering in Missouri on December 1
-
Fortrea Completes $75.7 Million Senior Notes Tender Offer Utilizing Cash on Hand
-
Newton Golf Announces Insider Share Purchases After Strong Q3 Results
-
Brunswick Exploration to Begin a Lithium Exploration Initiative in the Kingdom of Saudi Arabia
-
A New Sheriff In Town: HyOrc Saddles Up To Power the LA-SF Rail Corridor
-
Calian Awarded Contract to Deliver Four Ka/Q/V-Band Gateways for Two Geostationary Satellites
-
Biomea Fusion to Participate at Upcoming Investor Conferences
-
Sionna Therapeutics to Participate in Upcoming December Investor Conferences
-
Tilray Unveils Good Supply Vapes in Québec Following the Recent Introduction of Vape Products in Québec
-
Arvinas Announces Data Presentations from the Vepdegestrant (ARV-471) Clinical Development Program at the 2025 San Antonio Breast Cancer Symposium (SABCS)
-
Institutional Shareholder Services (ISS) Recommend Tiptree Stockholders Vote “FOR” the Merger of Fortegra and DB Insurance
-
Galvanize Therapeutics Appoints Laura Francis to its Board of Directors

